| Giovanna Elizabeth Mariano, MD | |
|
2255 E Mossy Oaks Rd Ste 320, Spring, TX 77389-1812 | |
| (936) 266-2195 | |
| Not Available |
| Full Name | Giovanna Elizabeth Mariano |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 2255 E Mossy Oaks Rd Ste 320, Spring, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265608293 | NPI | - | NPPES |
| 036129705 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | Q0185 (Texas) | Primary |
| 207Q00000X | Family Medicine | 036129705 (Illinois) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor St Lukes Medical Group | 9133213192 | 169 |
News Archive
Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences, Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.
Arthur J. Gallagher & Co. today announced the acquisition of the healthcare consulting firm, The Benfield Group. Headquartered in St. Louis, the firm also has offices in Chicago, Washington, D.C. and Atlanta.
After examining the genes of more than 200,000 people all over the world who have type-2 diabetes, researchers from the Perelman School of Medicine at the University of Pennsylvania and the Veterans Health Administration's Corporal Michael J. Crescenz Veterans Affairs Medical Center found hundreds of genetic variants never before linked to the disease.
The U.S. Food and Drug Administration today issued a draft guidance aimed at fostering early-stage development of medical devices within the United States. Doing early-stage development is important to help stimulate U.S.-based innovation and contribute to medical research.
› Verified 3 days ago
| Entity Name | Baylor St Lukes Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740485879 PECOS PAC ID: 9133213192 Enrollment ID: O20070920000863 |
News Archive
Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences, Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.
Arthur J. Gallagher & Co. today announced the acquisition of the healthcare consulting firm, The Benfield Group. Headquartered in St. Louis, the firm also has offices in Chicago, Washington, D.C. and Atlanta.
After examining the genes of more than 200,000 people all over the world who have type-2 diabetes, researchers from the Perelman School of Medicine at the University of Pennsylvania and the Veterans Health Administration's Corporal Michael J. Crescenz Veterans Affairs Medical Center found hundreds of genetic variants never before linked to the disease.
The U.S. Food and Drug Administration today issued a draft guidance aimed at fostering early-stage development of medical devices within the United States. Doing early-stage development is important to help stimulate U.S.-based innovation and contribute to medical research.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Giovanna Elizabeth Mariano, MD 8111 Cypresswood Dr Ste 103, Spring, TX 77379-7180 Ph: (281) 205-8240 | Giovanna Elizabeth Mariano, MD 2255 E Mossy Oaks Rd Ste 320, Spring, TX 77389-1812 Ph: (936) 266-2195 |
News Archive
Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences, Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.
Arthur J. Gallagher & Co. today announced the acquisition of the healthcare consulting firm, The Benfield Group. Headquartered in St. Louis, the firm also has offices in Chicago, Washington, D.C. and Atlanta.
After examining the genes of more than 200,000 people all over the world who have type-2 diabetes, researchers from the Perelman School of Medicine at the University of Pennsylvania and the Veterans Health Administration's Corporal Michael J. Crescenz Veterans Affairs Medical Center found hundreds of genetic variants never before linked to the disease.
The U.S. Food and Drug Administration today issued a draft guidance aimed at fostering early-stage development of medical devices within the United States. Doing early-stage development is important to help stimulate U.S.-based innovation and contribute to medical research.
› Verified 3 days ago
Dr. William Min-choy Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8411 Louetta Rd, Spring, TX 77379 Phone: 281-893-5870 Fax: 281-893-5895 | |
Mohammad Nameer Sidiquee, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7105 Fm 2920 Rd, Spring, TX 77379 Phone: 281-737-0902 | |
Dr. Andrew Spafford, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6401 Cypresswood Dr, Suite 180, Spring, TX 77379 Phone: 281-866-7080 Fax: 281-866-7151 | |
Huong T Le, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2306 Rayford Rd, Spring, TX 77386 Phone: 281-453-7777 | |
Randall Feuer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 21301 Kuykendahl Rd, Spring, TX 77379 Phone: 346-336-6904 Fax: 346-336-6910 | |
Marissa Pangan, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3466 Discovery Creek Blvd, Spring, TX 77386 Phone: 281-440-5300 | |
Mrs. Sushma V Gorrela, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6225 Fm 2920 Rd, Suite 100, Spring, TX 77379 Phone: 281-257-5977 Fax: 281-257-5966 |